Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Oral Oncology|July 30, 2013
Vascular priming enhances chemotherapeutic efficacy against head and neck cancerMargaret Folaron, James Kalmuk, Jaimee Lockwood, et al.Cancer Nanotechnology|February 19, 2021
Excretable, ultrasmall hexagonal NaGdF<sub>4</sub>:Yb50% nanoparticles for bimodal imaging and radiosensitizationJossana A Damasco, Tymish Y Ohulchanskyy, Supriya Mahajan, et al.Biorxiv : the Preprint Server for Biology|December 4, 2023
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.Cells|June 28, 2023
Phospholipid Encapsulation of an Anti-Fibrotic Endopeptide to Enhance Cellular Uptake and Myocardial RetentionSwati D Sonkawade, Shirley Xu, Minhyung Kim, et al.International Journal of Molecular Sciences|February 24, 2024
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and PromisesWen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.Journal of Medicinal Chemistry|June 28, 2022
Tumor-Avid 3-(1'-Hexyloxy)ethyl-3-devinylpyrpyropheophorbide-a (HPPH)-3Gd(III)tetraxetan (DOTA) Conjugate Defines Primary Tumors and MetastasesRavindra R Cheruku, Steven G Turowski, Farukh A Durrani, et al.Immunology|May 10, 2016
Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesisRavikumar Aalinkeel, Bindukumar Nair, Chih-Kuang Chen, et al.Cancer Cell|February 5, 2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerAftab Alam, Eric Levanduski, Parker Denz, et al.Pageof 8